Healthcare AI Vendor Assessment: Evaluation Checklists and Criteria

# Healthcare AI Vendor Assessment: Evaluation Checklists and Criteria *Published by the AI Accountability Standards Council | Healthcare AI Governance* --- ## Executive Summary As artificial intelligence tools become increasingly embedded in clinical workflows, diagnostic support, and administrative operations, healthcare organizations face growing pressure to evaluate vendors through a rigorous, structured lens. Selecting a healthcare AI vendor without a systematic assessment process may expose organizations to patient safety risks, regulatory complications, and operational disruptions. This guide provides compliance and business professionals with practical evaluation criteria aligned with leading frameworks, including the EU AI Act, NIST AI RMF, and ISO 42001. --- ## Key Considerations ### 1. Regulatory Classification and Risk Tier Not all healthcare AI systems carry equal risk. A scheduling optimization tool and an AI-assisted radiology diagnostic system occupy fundamentally different positions on the risk spectrum — and should be evaluated accordingly. Under the **EU AI Act**, several healthcare AI applications are classified as high-risk systems, meaning they require providers to maintain stricter oversight, transparency documentation, and human review protocols. Similarly, in the United States, the FDA has issued evolving guidance on Software as a Medical Device (SaMD), which may apply to AI tools involved in diagnosis, treatment planning, or patient monitoring. Organizations typically benefit from establishing a risk tier classification before beginning vendor conversations. This helps procurement teams ask the right questions early and allocate due diligence resources proportionately. ### 2. Transparency and Explainability One of the most frequent failure points in healthcare AI procurement is insufficient attention to model transparency. A vendor may be able to demonstrate strong performance metrics on benchmark datasets — but those metrics mean very little if clinical staff cannot understand how decisions are being generated. Best practices suggest requesting detailed documentation on: - **Model architecture and training methodology** - **Explainability mechanisms** (e.g., SHAP values, LIME, or proprietary explanation layers) - **Known performance disparities** across demographic subgroups The NIST AI Risk Management Framework (AI RMF) specifically highlights "explainability" and "interpretability" as distinct but related properties, both of which are relevant in clinical contexts where care decisions may be influenced by AI outputs. ### 3. Data Governance and Privacy Alignment Healthcare data is among the most sensitive information organizations handle. Vendors processing or training on patient data must demonstrate robust data governance practices that align with applicable privacy regulations, including HIPAA in the United States and GDPR in the European Union. Procurement teams should not assume that a vendor's general privacy policy covers all relevant scenarios. Organizations typically find it valuable to request a detailed **data processing agreement**, evidence of de-identification procedures, and clear policies on whether patient data is used to retrain or improve models after deployment. ### 4. Post-Deployment Monitoring Commitments AI model performance can degrade over time as clinical populations shift, care protocols evolve, or data infrastructure changes — a phenomenon commonly referred to as **model drift**. A vendor's commitments before sale may look very different from their support posture after contract execution. ISO 42001, the emerging international standard for AI management systems, emphasizes the importance of ongoing monitoring and governance as continuous obligations rather than one-time checkboxes. Organizations should probe vendors on their monitoring cadence, escalation procedures, and contractual obligations when performance thresholds are not met. --- ## Implementation Framework A structured vendor assessment may be organized into four sequential phases: **Phase 1 — Landscape and Classification** Define the intended use case, map it to applicable regulatory categories, and establish an internal risk tier. Document which clinical workflows or decisions the AI system may influence. **Phase 2 — Pre-Qualification Screening** Develop a short-form questionnaire (typically 15–25 questions) to screen vendors for baseline alignment with your organization's requirements. This may include questions on data residency, regulatory filings, audit history, and clinical validation studies. **Phase 3 — Deep-Dive Due Diligence** For vendors passing initial screening, conduct a structured technical review including documentation review, reference checks with peer institutions, and potentially a pilot deployment with predefined success metrics. Request independent validation studies where available. **Phase 4 — Ongoing Vendor Governance** Formalize the relationship through contract terms that include performance benchmarks, incident reporting requirements, change notification protocols, and defined review periods. Assign internal ownership for ongoing vendor relationship management. --- ## Documentation Requirements Healthcare organizations evaluating AI vendors should maintain documented records of the following throughout and after the procurement process: - **Business justification and use case definition**, including the clinical problem the AI system is intended to address - **Risk classification rationale**, aligned with applicable regulatory frameworks - **Vendor responses to assessment questionnaires**, preserved as part of the procurement record - **Clinical validation evidence reviewed**, including dataset characteristics and performance statistics - **Data processing agreements and privacy impact assessments** - **Internal review and approval workflows**, including which stakeholders participated in evaluation decisions - **Post-deployment monitoring plans** with defined performance thresholds and review schedules Thorough documentation may support organizations in demonstrating accountable AI procurement practices to internal governance bodies, auditors, or regulators. --- ## Risk Assessment Checklist When evaluating a healthcare AI vendor, organizations typically assess the following risk dimensions: **Clinical and Patient Safety Risks** - Has the system been clinically validated on populations similar to your patient base? - Are there known performance gaps by age, race, sex, or comorbidity status? - What fail-safes exist if the system generates an anomalous output? **Regulatory and Legal Risks** - Does the system require FDA clearance or EU AI Act high-risk conformity assessment? - Is the vendor able to provide documentation supporting your organization's regulatory obligations? - What is the vendor's track record with regulatory agencies or past audits? **Operational and Integration Risks** - How does the system integrate with existing EHR or clinical information infrastructure? - What downtime or service interruption history has the vendor experienced? - Are training and change management resources included in the vendor agreement? **Data and Privacy Risks** - Where is patient data stored and processed? - Is the vendor able to support data deletion requests? - Has the vendor undergone independent security audits, and are results available for review? **Vendor Stability Risks** - What is the vendor's funding and financial stability outlook? - What contractual protections exist if the vendor is acquired or discontinues the product? --- ## Best Practices Industry experience and emerging standards suggest several practices that may strengthen healthcare AI vendor assessment programs: - **Involve clinical staff early.** Procurement decisions made without input from frontline clinicians frequently encounter adoption resistance. Structured clinical user feedback during pilot phases tends to surface practical usability concerns that technical evaluations may miss. - **Request comparative benchmarking.** Rather than accepting vendor-provided performance claims at face value, ask how the system performs relative to established clinical benchmarks or competing approaches. - **Build a multidisciplinary review team.** Effective AI vendor evaluation typically draws on legal, clinical, IT, privacy, and compliance expertise. No single function is equipped to assess all relevant risk dimensions. - **Treat the vendor agreement as a governance document.** Contract terms around model updates, performance reporting, and incident disclosure are governance mechanisms — and should be reviewed with the same rigor as technical evaluation criteria. - **Revisit assessments periodically.** A vendor that met your organization's standards at procurement may not meet them two years later. Building structured annual or biennial reassessment cycles into vendor management programs may help organizations stay ahead of emerging risks. --- ## Next Steps Establishing a robust healthcare AI vendor assessment program is a meaningful undertaking, and organizations rarely need to start from scratch. The **AI Accountability Standards Council** offers a range of free tools and resources designed to support compliance and governance professionals at every stage of AI procurement — including downloadable assessment questionnaire templates, framework alignment guides, and sector-specific guidance for healthcare environments. We encourage organizations to explore the AASC resource library and consider connecting with our practitioner community to share challenges and approaches with peers navigating similar decisions. Building accountable AI governance in healthcare is a shared responsibility — and practical, well-documented frameworks are a foundational step in that direction. --- *This article is intended for educational purposes and reflects general guidance based on publicly available frameworks and industry practice. Organizations should consult qualified legal and regulatory advisors for guidance specific to their circumstances.* --- **Keywords:** healthcare AI vendors, medical AI procurement, AI vendor evaluation **Category:** Healthcare AI Governance **Published by:** AI Accountability Standards Council (AASC)